David R Epstein - Net Worth and Insider Trading
David R Epstein Net Worth
The estimated net worth of David R Epstein is at least $32 Million dollars as of 2024-05-06. David R Epstein is the CEO of Seagen Inc and owns about 136,598 shares of Seagen Inc (SGEN) stock worth over $31 Million. David R Epstein is the Director of Rubius Therapeutics Inc and owns about 4,720,012 shares of Rubius Therapeutics Inc (RUBY) stock worth over $269,041. David R Epstein is also the Director of Axcella Health Inc and owns about 6,446 shares of Axcella Health Inc (AXLA) stock worth over $2,584. Besides these, David R Epstein also holds Evelo Biosciences Inc (EVLO) . Details can be seen in David R Epstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David R Epstein has not made any transactions after 2023-11-10 and currently still holds the listed stock(s).
Transaction Summary of David R Epstein
David R Epstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David R Epstein owns 8 companies in total, including Evelo Biosciences Inc (EVLO) , Axcella Health Inc (AXLA) , and Rubius Therapeutics Inc (RUBY) among others .
Click here to see the complete history of David R Epstein’s form 4 insider trades.
Insider Ownership Summary of David R Epstein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EVLO | Evelo Biosciences Inc | 2022-05-27 | director |
AXLA | Axcella Health Inc | 2022-03-16 | director |
RUBY | Rubius Therapeutics Inc | 2022-04-21 | director |
2016-01-01 | director | ||
2021-05-25 | director | ||
2021-10-26 | director | ||
2021-05-25 | director | ||
2023-11-10 | director & Chief Executive Officer |
David R Epstein Latest Holdings Summary
David R Epstein currently owns a total of 4 stocks. Among these stocks, David R Epstein owns 136,598 shares of Seagen Inc (SGEN) as of November 10, 2023, with a value of $31 Million and a weighting of 99.14%. David R Epstein owns 4,720,012 shares of Rubius Therapeutics Inc (RUBY) as of April 21, 2022, with a value of $269,041 and a weighting of 0.85%. David R Epstein also owns 6,446 shares of Axcella Health Inc (AXLA) as of March 16, 2022, with a value of $2,584 and a weighting of 0.01%. The other 1 stocks Evelo Biosciences Inc (EVLO) have a combined weighting of 0% among all his current holdings.
Latest Holdings of David R Epstein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2023-11-10 | 136,598 | 228.74 | 31,245,427 |
RUBY | Rubius Therapeutics Inc | 2022-04-21 | 4,720,012 | 0.06 | 269,041 |
AXLA | Axcella Health Inc | 2022-03-16 | 6,446 | 0.40 | 2,584 |
EVLO | Evelo Biosciences Inc | 2022-05-27 | 4,204 | 0.04 | 183 |
Holding Weightings of David R Epstein
David R Epstein Form 4 Trading Tracker
According to the SEC Form 4 filings, David R Epstein has made a total of 1 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Seagen Inc is the sale of 10,620 shares on November 10, 2023, which brought David R Epstein around $2 Million.
According to the SEC Form 4 filings, David R Epstein has made a total of 5 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 30,000 shares on April 21, 2022, which cost David R Epstein around $43,200.
According to the SEC Form 4 filings, David R Epstein has made a total of 11 transactions in Axcella Health Inc (AXLA) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Axcella Health Inc is the acquisition of 1,047 shares on March 16, 2022, which cost David R Epstein around $50,000.
More details on David R Epstein's insider transactions can be found in the Insider Trading History of David R Epstein table.Insider Trading History of David R Epstein
- 1
David R Epstein Trading Performance
GuruFocus tracks the stock performance after each of David R Epstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David R Epstein is 3.11%. GuruFocus also compares David R Epstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by David R Epstein within 3 months outperforms 8 times out of 17 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David R Epstein's insider trading performs compared to the benchmark.
Performance of David R Epstein
David R Epstein Ownership Network
Ownership Network List of David R Epstein
Ownership Network Relation of David R Epstein
David R Epstein Owned Company Details
What does Evelo Biosciences Inc do?
Who are the key executives at Evelo Biosciences Inc?
David R Epstein is the director of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .
Evelo Biosciences Inc (EVLO) Insider Trades Summary
Over the past 18 months, David R Epstein made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 103,730 shares made by Mark Bodmer , a net sale of 80,121 shares made by Duncan Mchale , and a net sale of 46,345 shares made by Marella Thorell .
In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 46,837 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,364,418 shares.
Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evelo Biosciences Inc Insider Transactions
David R Epstein Mailing Address
Above is the net worth, insider trading, and ownership report for David R Epstein. You might contact David R Epstein via mailing address: International Flavors & Fragrances Inc., 521 W. 57th Street, New York Ny 10019.